Serial Number
88783933
Owner
TEMPUS AI, INC.Attorney
Jeremy D. BisdorfFirst Use Date
Jan 11, 2021
Filing Date
Feb 4, 2020
TEMPUS Trademark
Serial Number: 88783933 • Registration: 6880461
Trademark Classes
Owner Contact Info
600 WEST CHICAGO AVENUE, SUITE 510
CHICAGO, IL 60654
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
February 4, 2020
Registration Date
October 18, 2022
First Use Anywhere
January 11, 2021
First Use in Commerce
January 11, 2021
Published for Opposition
March 9, 2021
Goods & Services
Medical research in the fields of diabetes, neurology, and depression diagnostics and testing; medical and scientific research related to diabetes, neurology, and depression diagnostics and testing; providing medical and scientific research information in the fields of diabetes, neurology, and depression diagnostics and testing; medical and scientific research in the fields of diabetes, neurology, and depression diagnostics and testing; research and development services in the fields of diabetes, neurology, and depression diagnostics and testing; Computer system analysis for use in diabetes, neurology, and depression diagnostics and testing; computer system design for use in diabetes, neurology, and depression diagnostics and testing; software development for diagnostics and medical, clinical and research testing in the fields of diabetes, neurology, and depression diagnostics and testing; Platform as a service (PAAS) featuring computer software platforms for providing users with clinical decision support in the fields of diabetes, neurology, and depression diagnostics and testing; Software as a service services (SAAS) featuring software for providing users with clinical decision support in the fields of diabetes, neurology, and depression diagnostics and testing; Platform as a service (PAAS) for providing users with clinical decision support in the fields of diabetes, neurology, and depression diagnostics and testing; Software as a service services (SAAS) featuring software using artificial intelligence for machine learning to support clinical data platforms in the fields of diabetes, neurology, and depression diagnostics and testing; platform as a service (PAAS) featuring software using artificial intelligence for machine learning to support clinical data platforms in the fields of diabetes, neurology, and depression diagnostics and testing
